Remote Patient Monitoring Market Growth, Trends, Size, Share, Revenue and Future Outlook
Remote Patient Monitoring Market Growth, Size, Trends Analysis - By Component, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Sep-2021 | Report ID: HLCA2115 | Pages: 1 - 249 | Formats*: |
| Category : Healthcare | |||
Global Remote Patient Monitoring Market Introduction and Overview
According to SPER Market Research, the Global Remote Patient Monitoring Market is estimated to reach USD 748.85 billion by 2034 with a CAGR of 23.85%.
The report includes an in-depth analysis of the Global Remote Patient Monitoring Market, including market size and trends, product mix, Applications, and supplier analysis.
The global remote patient monitoring market, which was valued at US$66.63 billion in 2023, is expected to rise at a CAGR of 23.85% to reach US$240.47 billion by 2029. The remote patient monitoring (RPM) market is expanding due to the cost savings associated with RPM adoption in the healthcare industry. Furthermore, there is a rising emphasis on patient-centered care, and RPM encourages individuals to actively participate in their own health management. This is consistent with the trend of personalized medicine and patient interaction, which will drive the RPM market throughout the projected period. However, legal differences across nations and the informal use of social media practices may limit market growth during the forecast period.
Our in-depth analysis of the Global Remote Patient Monitoring Market includes the following segments:
By Component Insights
The remote patient monitoring industry's software and services segment is predicted to grow at the fastest rate over the forecast period. Remote patient monitoring is classified into two categories: software and services, and equipment. Throughout the forecast period, the software and services category is expected to grow at a faster rate. This segment's rapid expansion is mostly attributable to patients and other end users' increasing preference for preventative care adoption outside of hospital settings, the convenience and usability of RPM devices, and the adoption of AI.
By Application Insights
The market for remote patient monitoring is segmented based on applications, including oncology, neurological, cardiovascular, respiratory, and diabetes conditions. The diabetes industry is expected to hold the largest market share in 2024. The growing prevalence of chronic diseases, the greater need to monitor diabetic patients, and the growing use of telemedicine are all factors contributing to this category's large market share.
By End User Insights
In 2024, the home-care settings segment is anticipated to hold the largest market share.
The market for remote patient monitoring is divided into many end users, including long-term care facilities, hospitals, and home-care settings. The home-care settings segment is anticipated to hold the biggest market share in 2024. The growing trend toward home-care settings, the increasing incidence of chronic diseases among the elderly, the lack of qualified healthcare workers, and growing consumer awareness of the use of RPM tools for chronic condition monitoring are all factors contributing to this segment's substantial market share.
By Regional Insights
The remote patient monitoring market is expected to grow at the fastest rate in Asia-Pacific over the course of the forecast period. A large target population, rising personal disposable incomes, rising consumer awareness, the prevalence of infectious and chronic diseases, and government programs encouraging the use of remote patient monitoring systems are all factors contributing to the growth of this regional market.
Market Competitive Landscape
The major trend in the market includes improving current technologies, launching new products, expanding product lines, and forming partnerships with healthcare facilities. In August 2023, GE HealthCare got FDA approval for a patient monitoring system with wearable sensors. Some of the key market players are Biotronik SE & Co. KG, Alive Cor, Inc, TytoCare Ltd, Teledoc Health Inc, Vivify Health, Inc, Koninklijke Philips N.V, Brook Inc, Blue Spark Technology, Welch Allyn, Health Beats, Medtronic, Oracle, Siemens Healthineers AG, Omron Healthcare, Boston Scientific Corporation, Clear Arch, Inc, GE Healthcare, Abbott Laboratories, Alten Calsoft Labs, Bio-Beat.
Recent Developments:
- In January 2024, LifeSigns, a leading AI-powered health monitoring technology company, and Apollo Hospital, a well-known multispecialty hospital in India, announced a groundbreaking partnership.
- In August 2023, EPIC Health worked together to tackle health inequities and lower heart attack and stroke risks in underserved communities in Detroit. The program will use VitalSight, OMRON's remote patient monitoring service for patients with high blood pressure, particularly those with uncontrolled Stage 2 hypertension.
- In January 2022, OMRON Healthcare, Inc., a world leader in personal health technology and remote blood pressure monitoring, announced new remote patient monitoring services, connected blood pressure monitors, and a cutting-edge mobile app at the 2022 Consumer Electronics Show (CES).
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Component, By Application, By End User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Biotronik SE & Co. KG, Alive Cor, Inc, TytoCare Ltd, Teledoc Health Inc, Vivify Health, Inc, Koninklijke Philips N.V, Brook Inc, Blue Spark Technology, Welch Allyn, Health Beats, Medtronic, Oracle, Siemens Healthineers AG, Omron Healthcare, Boston Scientific Corporation, Clear Arch, Inc, GE Healthcare, Abbott Laboratories, Alten Calsoft Labs, Bio-Beat. |
Key Topics Covered in the Report:
- Global Remote Patient Monitoring Market Size (FY’2025-FY’2034)
- Overview of Global Remote Patient Monitoring Market
- Segmentation of Global Remote Patient Monitoring Market By Component (Services & Software, Devices)
- Segmentation of Global Remote Patient Monitoring Market By Application (Oncology, Cardiovascular Diseases, Diabetes, Sleep Disorders, Weight Management & Fitness Monitoring)
- Segmentation of Global Remote Patient Monitoring Market By End User (Hospitals and Clinics, Home Care Settings and Long Term Care Centers, Ambulatory Care Centers, Other End Users)
- Statistical Snap of Global Remote Patient Monitoring Market
- Expansion Analysis of Global Remote Patient Monitoring Market
- Problems and Obstacles in Global Remote Patient Monitoring Market
- Competitive Landscape in the Global Remote Patient Monitoring Market
- Details on Current Investment in Global Remote Patient Monitoring Market
- Competitive Analysis of Global Remote Patient Monitoring Market
- Prominent Players in the Global Remote Patient Monitoring Market
- SWOT Analysis of Global Remote Patient Monitoring Market
- Global Remote Patient Monitoring Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Remote Patient Monitoring Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Remote Patient Monitoring Market
7. Global Remote Patient Monitoring Market, By Component (USD Million) 2025-2034
7.1. Services & Software7.2. Devices7.2.1. Cardiac Monitoring Devices7.2.2. Neurological Monitoring Devices7.2.3. Respiratory Monitoring Devices7.2.4. Multiparameter Monitoring Devices7.2.5. Blood Glucose Monitoring Devices7.2.6. Fetal & Neonatal Monitoring Devices7.2.7. Weight Monitoring Devices7.2.8. Other Monitoring Devices
8. Global Remote Patient Monitoring Market, By Application (USD Million) 2025-2034
8.1. Oncology8.2. Cardiovascular Diseases8.3. Diabetes8.4. Sleep Disorders8.5. Weight Management & Fitness Monitoring
9. Global Remote Patient Monitoring Market, By End User (USD Million) 2025-2034
9.1. Hospitals and Clinics9.2. Home Care Settings and Long-Term Care Centers9.3. Ambulatory Care Centers9.4. Other End Users
10. Global Remote Patient Monitoring Market Forecast, 2025-2034 (USD Million)
10.1. Global Remote Patient Monitoring Market Size and Market Share
11. Global Remote Patient Monitoring Market, By Region, 2025-2034 (USD Million)
11.1. Asia-Pacific11.1.1. Australia11.1.2. China11.1.3. India11.1.4. Japan11.1.5. South Korea11.1.6. Rest of Asia-Pacific11.2. Europe11.2.1. France11.2.2. Germany11.2.3. Italy11.2.4. Spain11.2.5. United Kingdom11.2.6. Rest of Europe11.3. Middle East and Africa11.3.1. Kingdom of Saudi Arabia11.3.2. United Arab Emirates11.3.3. Qatar11.3.4. South Africa11.3.5. Egypt11.3.6. Morocco11.3.7. Nigeria11.3.8. Rest of Middle-East and Africa11.4. North America11.4.1. Canada11.4.2. Mexico11.4.3. United States11.5. Latin America11.5.1. Argentina11.5.2. Brazil11.5.3. Rest of Latin America
12. Company Profile
12.1. Biotronik SE & Co. KG12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments12.2. Alive Cor, Inc12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments12.3. TytoCare Ltd12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments12.4. Teledoc Health Inc12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments12.5. Vivify Health, Inc12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments12.6. Koninklijke Philips N.V12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments12.7. Brook Inc12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments12.8. Blue Spark Technology12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments12.9. Welch Allyn12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments12.10. Health Beats12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments12.11. Medtronic12.11.1. Company details12.11.2. Financial outlook12.11.3. Product summary12.11.4. Recent developments12.12. Oracle12.12.1. Company details12.12.2. Financial outlook12.12.3. Product summary12.12.4. Recent developments12.13. Siemens Healthineers AG12.13.1. Company details12.13.2. Financial outlook12.13.3. Product summary
12.13.4. Recent developments
12.14. Omron Healthcare12.14.1. Company details12.14.2. Financial outlook12.14.3. Product summary12.14.4. Recent developments12.15. Boston Scientific Corporation12.15.1. Company details12.15.2. Financial outlook12.15.3. Product summary12.15.4. Recent developments12.16. Clear Arch, Inc12.16.1. Company details12.16.2. Financial outlook12.16.3. Product summary12.16.4. Recent developments12.17. GE Healthcare12.17.1. Company details12.17.2. Financial outlook12.17.3. Product summary12.17.4. Recent developments12.18. Abbott Laboratories12.18.1. Company details12.18.2. Financial outlook12.18.3. Product summary12.18.4. Recent developments12.19. Alten Calsoft Labs12.19.1. Company details12.19.2. Financial outlook12.19.3. Product summary12.19.4. Recent developments12.20. Bio-Beat12.20.1. Company details12.20.2. Financial outlook12.20.3. Product summary12.20.4. Recent developments12.21. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Remote Patient Monitoring Market is projected to reach USD 748.85 billion by 2034, growing at a CAGR of 23.85% during the forecast period.
Remote Patient Monitoring Market grew in Market size from 2025. The Market is expected to reach USD 748.85 billion by 2034, at a CAGR of 23.85% during the forecast period.
Remote Patient Monitoring Market CAGR of 23.85% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Remote Patient Monitoring Market size is USD 748.85 billion from 2025 to 2034.
Remote Patient Monitoring Market is covered By Component, By Application, By End User
The North America is anticipated to have the highest Market share in the Remote Patient Monitoring Market.
The Key players in the Market include Companies Covered Biotronik SE & Co. KG, Alive Cor, Inc, TytoCare Ltd, Teledoc Health Inc, Vivify Health, Inc, Koninklijke Philips N.V, Brook Inc, Blue Spark Technology, Welch Allyn, Health Beats, Medtronic, Oracle, Siemens Healthineers AG, Omron Healthcare, Boston Scientific Corporation, Clear Arch, Inc, GE Healthcare, Abbott Laboratories, Alten Calsoft Labs, Bio-Beat.
The high cost of advanced diabetes drugs and the financial burden of treating diabetes remain major obstacles to market growth, despite the fact that numerous drugs have been approved for the condition and that governments and industry players are launching numerous initiatives.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
